Become a Member

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Solvonis Therap (SVNS) Share Price

Buy/Sell	Volume	Trade Prc	Trade Type	Trade Time
Solvonis Therap (SVNS) Latest Trades
Sell*	217,392	0.235p	Uncrossing Trade	16:35:07 - 20-Mar-26
Sell*	1,000,000	0.23p	Negotiated Trade	16:23:03 - 20-Mar-26
Unknown*	1,546	0.24p	Ordinary	15:45:16 - 20-Mar-26
Sell*	200,000	0.23p	Ordinary	14:07:10 - 20-Mar-26
Buy*	200,000	0.25p	Suspected BUY Trade	14:00:11 - 20-Mar-26
Sell*	125,000	0.2302p	Ordinary	13:53:42 - 20-Mar-26
Sell*	125,000	0.2302p	Ordinary	13:53:26 - 20-Mar-26
Sell*	150,000	0.2302p	Ordinary	13:50:52 - 20-Mar-26
Sell*	10,011	0.23p	Ordinary	13:19:53 - 20-Mar-26
Sell*	666,667	0.2345p	Ordinary	12:56:10 - 20-Mar-26

See more Solvonis Therap trades

Solvonis Therap (SVNS) Share Price History
Time period: to
Date	Open	High	Low	Close	Volume
20th Mar 2026 (Fri)	0.24	0.25	0.235	0.235	4,117,621
19th Mar 2026 (Thu)	0.24	0.24	0.24	0.24	47,626,956
18th Mar 2026 (Wed)	0.25	0.24	0.24	0.24	17,604,274
17th Mar 2026 (Tue)	0.255	0.25	0.245	0.245	7,408,623
16th Mar 2026 (Mon)	0.25	0.255	0.24	0.24	53,484,417
13th Mar 2026 (Fri)	0.23	0.25	0.23	0.25	50,551,097
12th Mar 2026 (Thu)	0.215	0.23	0.23	0.23	71,052,043
11th Mar 2026 (Wed)	0.225	0.225	0.215	0.215	26,352,912
10th Mar 2026 (Tue)	0.23	0.23	0.225	0.225	24,051,268
9th Mar 2026 (Mon)	0.225	0.224	0.224	0.224	15,874,648
6th Mar 2026 (Fri)	0.225	0.225	0.225	0.225	12,661,258
5th Mar 2026 (Thu)	0.225	0.23	0.225	0.225	17,187,448
4th Mar 2026 (Wed)	0.232	0.232	0.225	0.225	16,765,089
3rd Mar 2026 (Tue)	0.24	0.24	0.235	0.235	21,823,388
2nd Mar 2026 (Mon)	0.25	0.23	0.23	0.23	13,199,755
27th Feb 2026 (Fri)	0.24	0.25	0.24	0.25	47,525,243
26th Feb 2026 (Thu)	0.235	0.25	0.23	0.25	19,323,065
25th Feb 2026 (Wed)	0.215	0.225	0.222	0.225	51,833,242
24th Feb 2026 (Tue)	0.225	0.23	0.219	0.219	49,583,588
23rd Feb 2026 (Mon)	0.235	0.23	0.22	0.23	81,409,753

See more Solvonis Therap price history

Date	Source	Headline
Solvonis Therap (SVNS) Regulatory News
10th Mar 2026 7:00 am	RNS	SVN-114 selected for PTSD discovery programme
28th Jan 2026 7:00 am	RNS	Expansion of SVN-015 into depression
7th Jan 2026 7:00 am	RNS	US Patent allowance for PTSD discovery programme
22nd Dec 2025 7:00 am	RNS	Research and Development Update - Q4 2025
22nd Dec 2025 7:00 am	RNS	Research and Development Update – Q4 2025
3rd Dec 2025 7:00 am	RNS	SVN-015 accepted into US NIDA funded programme
31st Oct 2025 3:59 pm	RNS	Total Voting Rights
31st Oct 2025 7:00 am	RNS	Corporate Structure Update and Issue of Options
27th Oct 2025 7:00 am	RNS	Appoints global biopharma leader Paul Carter
16th Oct 2025 7:00 am	RNS	Raises £1.25 Million to Accelerate Programmes

See more Solvonis Therap regulatory news

FTSE 100 Latest

Value9,918.33

Change-145.17